Attention enhancing effects of methylphenidate are age-dependent
Shevon E Bhattacharya1, Jed S Shumsky1, Barry D Waterhouse1
1Drexel University College of Medicine, Philadelphia, PA 19129, United States.
Experimental Gerontology
|December 3, 2014
Summary
Methylphenidate (MPH) enhances attention in adult rats but not aged ones. This study suggests MPH may not be effective for cognitive enhancement in the elderly.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Science
Background:
- Methylphenidate (MPH) is a psychostimulant used for cognitive disorders.
- MPH is popular for enhancing attention and concentration in healthy individuals, including the elderly.
- Comparative effects of MPH on cognition in aged versus adult subjects are not well-established.
Purpose of the Study:
- To investigate the effects of MPH on sustained attention in adult and aged rats.
- To assess the impact of visual distraction on attention performance.
- To determine if MPH can mitigate distraction-induced performance deficits.
Main Methods:
- Adult (6-12 months) and aged (18-22 months) male Sprague-Dawley rats were used.
- Oral administration of methylphenidate (MPH).
- Cognitive and motor abilities were tested using a sustained attention task, with and without visual distraction.
Main Results:
- MPH improved sustained attention performance in adult rats.
- No significant improvement in sustained attention was observed in aged rats treated with MPH.
- MPH did not mitigate the negative impact of visual distraction on performance in either age group.
Conclusions:
- Methylphenidate (MPH) demonstrates age-dependent efficacy in improving sustained attention.
- The cognitive-enhancing effects of MPH observed in adults may not translate to aged individuals.
- Findings suggest MPH may be ineffective for cognitive enhancement in the elderly population.
More Related Videos
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.3K
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
10.4K
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.4K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
346
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
346
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
926
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
926
01:15Drug Dosing: Geriatric Patients
375
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
375
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
828
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
828
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
373
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373